Sie behalten den Überblick, wenn es um Menschen, Abläufe und Details geht. Unterstützen Sie Forschung, die Leben verändert!
Sie möchten nicht „nur Payroll machen“, sondern HR-Prozesse aktiv mitgestalten, Systeme weiterentwickeln und für stabile, zukunftsorientierte HR‑Abläufe sorgen?
Dann werden Sie Teil unseres HR‑Teams: Wir betreuen rund 230 Mitarbeitende aus über 30 Nationen in einem dynamischen, internationalen Forschungsumfeld.
Unsere Stärke liegt in einer Kombination aus professionellen HR‑Standards, pragmatischen Lösungen und einer wertschätzenden Zusammenarbeit.
In dieser Rolle übernehmen Sie eine zentrale Funktion im Bereich HR Payroll & Operations:
Sie sorgen für eine reibungslose Payroll‑Abwicklung und übernehmen eine zentrale Rolle in der Weiterentwicklung unserer HR‑Prozesse und Systeme.
Vorbereitung, Kontrolle und Nachbereitung der monatlichen Gehaltsverrechnung in Zusammenarbeit mit einem externen Payroll-Anbieter
Sicherstellung einer korrekten, termingerechten und qualitativ hochwertigen Payroll-Abwicklung
Erste Ansprechperson für Mitarbeitende und Führungskräfte bei payroll- und abrechnungsrelevanten Fragestellungen
Monitoring gesetzlicher Änderungen im Arbeits-, Sozialversicherungs- und Lohnsteuerrecht sowie deren interne Umsetzung
Ansprechpartner:in bei Prüfungen (z.B. GPLB)
Product Ownership für das HR‑System (DPW) inklusive Weiterentwicklung des Systems sowie Umsetzung und Ausbau neuer Funktionalitäten (z.B. Workflows, Automatisierungen)
Qualitätsverbesserungen
Erstellung und Weiterentwicklung von HR‑Auswertungen und Kennzahlen
Unterstützung der HR Administration im Rahmen definierter Vertretungsregelungen
Mitarbeit an Digitalisierungs- und Weiterentwicklungsprojekten im HR‑Bereich
Abgeschlossene kaufmännische Ausbildung auf Maturaniveua und mehrjährige Erfahrung in der Personalverrechnung oder im Payroll‑Umfeld
Gute Kenntnisse des österreichischen Arbeits- und Sozialversicherungsrechts
Erfahrung im Umgang mit HR‑Systemen (idealerweise DPW oder vergleichbare Systeme)
Sehr gute Excel‑Kenntnisse und Freude an der Arbeit mit Daten
Ausgeprägtes Verständnis für Prozesse und hohe Genauigkeit
Interesse an der Weiterentwicklung von Systemen und Abläufen
Strukturierte, eigenständige und lösungsorientierte Arbeitsweise sowie Freude an der Zusammenarbeit im Team
Kommunikationsstärke und Serviceorientierung
Strukturiertes Onboarding: Profitieren Sie von einer umfassenden Einschulung und praxisnaher Einarbeitung für einen reibungslosen Start
Gesunde Pausen: Genießen Sie vergünstigtes Mittagessen, frische Obstkörbe und eine bezahlte Mittagspause als Teil Ihrer Arbeitszeit
Flexibilität, die zu Ihrem Leben passt: Profitieren Sie von flexiblen Arbeitszeiten, Homeoffice Möglichkeiten und zusätzlichen freien Tagen
Professionelle Teamkultur: Arbeiten Sie in einem Team, das von Kooperation, offener Kommunikation und gegenseitigem Respekt geprägt ist
Inklusiv & Sinnstiftend: Arbeiten Sie in einem internationalen Umfeld mit einer bedeutungsvollen Mission
Zentrale Lage: Arbeiten Sie im Herzen Wiens – einem europäischen Zentrum für biomedizinische Forschung und einer Stadt mit hoher Lebensqualität
Ein faires und marktkonformes Gehalt ab mindestens € 2.800,- brutto (14x pro Jahr) auf Vollzeitbasis sowie die Bereitschaft zu einer höheren Entlohnung abhängig von Ihrer Qualifikation und beruflicher Erfahrung.
Transforming discovery into new therapeutic options for children with cancer!
At St. Anna Children's Cancer Research Institute (St. Anna CCRI), translational medicine is driven by a single purpose: turning scientific insight into tangible clinical impact for pediatric cancer patients. To further strengthen our portfolio in translational discovery and therapeutic development, we are seeking an outstanding Principal Investigator in Translational Medicine for Pediatric Cancer. This position is open to candidates at different career stages – from emerging group leaders to experienced Principal Investigators.
In this role, you will establish and lead an innovative research program dedicated to the discovery, validation, and development of novel therapeutic strategies, with a strong focus on one or more key modalities, e.g. small molecules, drug repurposing, immunotherapies, or biologics, embedded in a broader translational ecosystem covering complementary approaches, within a uniquely integrated bench‑to‑bedside environment closely linked to precision oncology and early‑phase clinical studies.
Establish and lead a translational research program in pediatric cancer therapy: Develop innovative therapeutic strategies with a clear primary focus in a key therapeutic modality, e.g. small molecules, drug repurposing, immunotherapies, or biological therapeutics, while maintaining a strong openness for collaborative integration across complementary approaches.
Drive discovery and therapeutic development: Lead target identification, mechanism‑of‑action studies, and compound screening efforts embedded in a translational pipeline.
Translate discovery into clinical concepts: Integrate research findings with precision oncology initiatives to enable biomarker‑informed and clinically relevant therapeutic strategies.
Strengthen early‑phase translational interfaces: Collaborate closely with the St. Anna CCRI Clinical Trials Unit, Statistics, and St. Anna Children's Hospital to support robust preclinical‑to‑clinical translation.
Build and lead a multidisciplinary research team: Recruit, mentor, and guide scientists while ensuring scientific rigor, reproducibility, and regulatory alignment.
Ensure visibility, collaboration and sustainability: Secure competitive third‑party funding, publish high‑impact research, and represent St. Anna CCRI in international translational medicine networks and consortia.
PhD or MD/PhD in biomedical sciences with demonstrated deep expertise in at least one therapeutic development modality (e.g. small molecules, biologics, immunotherapy), with the ability to position this expertise within broader translational strategies.
Postdoctoral research experience, with a strong publication track record.
Demonstrated experience in therapeutic development, including target identification, high-throughput or focused compound screening, and mechanism‑of‑action studies.
Familiarity with 2D/3D model systems and relevant in vivo models (e.g., zebrafish, PDX or other preclinical tumor models).
Proven success in securing competitive external funding and leading independent research.
Experience working in interdisciplinary and collaborative environments, ideally with clinical or translational partners.
Strong mentoring and leadership skills in supervising PhD Students, Postdocs, or scientific staff.
Excellent communication skills, with the ability to convey complex scientific findings clearly and to work effectively within collaborative, interdisciplinary research environments.
Excellent communication skills and fluency in English.
Our offer
Internal funding & strong institutional commitment: Competitive core budget and comprehensive start-up resources including dedicated laboratory space, access to core equipment, and support in building and scaling your independent research team.
Access to cutting‑edge research infrastructure: State‑of‑the‑art technology platforms in genomics, imaging, proteomics, high‑throughput screening, and advanced in vivo and ex vivo disease models, embedded in a strong translational ecosystem.
Embedded collaborative ecosystem: Close interaction with clinicians, precision oncology initiatives, early‑phase clinical trials, and interdisciplinary research groups across discovery and translational medicine.
Professional grant support: Institutional assistance with proposal development and professional grant management.
Attractive employment conditions, culture & location: Flexible working arrangements, tailored onboarding support for international researchers, and a diverse, mission‑driven culture dedicated to improving outcomes for children with cancer, based in Vienna, offering outstanding quality of life and a strong biomedical ecosystem.
Compensation: The minimum annual gross salary for this position is € 78.000.- (all in), with the possibility of higher compensation depending on qualifications and experience.
Contract terms: Appointment terms will be aligned with the candidate's career stage. Starting Principal Investigators will be offered a 5‑year appointment with the possibility of a further 4‑year extension following positive evaluation. Senior Principal Investigators may be appointed on a rolling tenure basis, with regular evaluations every 5 years, reflecting the institute's long‑term strategic commitment to scientific leadership.
Your application
We are looking forward to your application! The application deadline ends on 23.08.2026.
Please submit the following documents:
In case of questions please contact us at faculty-recruiting@ccri.at.
Your recruiting process
Our recruitment process is designed to ensure a fair, transparent, and rigorous evaluation. It includes the following steps:
Unlocking functional insights to accelerate precision therapies for children with cancer!
At St. Anna Children's Cancer Research Institute (St. Anna CCRI), innovative disease models play a critical role in translating molecular discoveries into effective treatments. To further strengthen our capabilities in pediatric cancer modeling and functional genomics, we are seeking an outstanding Principal Investigator in Zebrafish Models for Pediatric Cancer. This position is open to candidates at different career stages – from emerging group leaders to experienced Principal Investigators.
In this role, you will develop and lead a highly innovative zebrafish research program with a strong translational focus, bridging unmet clinical needs in pediatric oncology with functional insights derived from zebrafish models. Your work will directly contribute to accelerating therapeutic innovation and improving outcomes for young patients.
A central objective of this position is to expand and advance our established zebrafish-based xenograft and drug-screening approaches. This work builds on an exceptional foundation: a well-established zebrafish facility with a highly experienced core unit team, and the ZANDR drug-screening platform.
Lead a zebrafish research program for pediatric cancer: Build and develop an innovative program focused on functional disease modeling and translational applications.
Operate an institutional zebrafish platform: Scientifically contribute to and strategically shape an established zebrafish and drug‑screening core unit infrastructure.
Integrate functional modeling into translational pipelines: Implement zebrafish workflows tightly linked to St. Anna CCRI's precision oncology program, the biobank, and translational research pipelines.
Drive ambitious, translational research: Design and execute rigorous, reproducible research projects with clear relevance to pediatric cancer biology and therapy.
Build and lead a multidisciplinary team: Recruit, train, mentor, and supervise scientific and technical staff while ensuring high operational and quality standards.
Ensure visibility, collaboration and sustainability: Secure competitive third‑party funding, publish impactful research, and represent St. Anna CCRI in international research networks and consortia.
PhD, MD/PhD, or equivalent degree in biomedical sciences or a related field.
Our offer
Internal funding & strong institutional commitment: Competitive core budget and comprehensive start-up resources including dedicated laboratory space, access to core equipment, and support in building and scaling your independent research team.
Access to cutting‑edge research infrastructure: State‑of‑the‑art platforms in genomics, imaging, proteomics, high‑throughput screening, and advanced in vivo model systems integrated across the institute.
Embedded collaborative ecosystem: Close interaction with clinicians, precision oncology initiatives, the biobank, and interdisciplinary research groups within a highly translational environment.
Professional grant support: Institutional assistance with proposal development and professional grant management.
Attractive employment conditions, culture & location: Flexible working arrangements, tailored onboarding support for international researchers, and a diverse, mission‑driven culture, based in Vienna, offering outstanding quality of life and a strong biomedical ecosystem.
Compensation: The minimum annual gross salary for this position is € 78.000.- (all in), with the possibility of higher compensation depending on qualifications and experience.
Contract terms: Appointment terms will be aligned with the candidate's career stage: Starting Principal Investigators will be offered a 5‑year appointment with the possibility of a further 4‑year extension following positive evaluation, while Senior Principal Investigators may be appointed on a rolling tenure basis with regular evaluations every 5 years, reflecting the institute's long‑term commitment to scientific leadership.
Your application
We are looking forward to your application! The application deadline ends on 16.08.2026.
Please submit the following documents:
In case of questions please contact us at faculty-recruiting@ccri.at.
Your recruiting process
Our recruitment process is designed to ensure a fair, transparent, and rigorous evaluation. It includes the following steps:
Harnessing the power of the immune system to transform outcomes for children with cancer!
At St. Anna Children's Cancer Research Institute (St. Anna CCRI), we pursue our vision: turning scientific innovation into life‑changing therapies for pediatric cancer patients. To further strengthen our strategic focus on cellular engineering, immune‑based therapies, and translational innovation, we are seeking an outstanding Principal Investigator in Cellular & Immuno-Therapies for Pediatric Cancer. This position is open to candidates at different career stages – from emerging group leaders to experienced Principal Investigators.
In this role, you will establish and lead an internationally competitive research program at the forefront of engineered immune cell therapies and cancer vaccines, driving breakthroughs from discovery through preclinical validation to early clinical translation, within a uniquely integrated bench‑to‑bedside-and-back environment.
Establish and lead an independent research program in cellular or immuno-therapies: Develop innovative approaches in one or more core areas of cellular and immuno-therapy (e.g. engineered T/NK cells, CAR-based strategies, next-generation cell-based approaches, or cancer vaccines), with a clear emphasis on scientific depth and differentiation within a defined focus area.
Drive translational innovation from discovery to clinic: Advance immune‑engineering concepts through preclinical validation toward early‑phase clinical trials in close alignment with precision oncology initiatives.
Strengthen clinical and translational interfaces: Collaborate closely with the St. Anna CCRI Clinical Trials Unit, pediatric oncology teams, and GMP facilities at partnering institutions to align research, manufacturing, and regulatory pathways.
Build and lead a high‑performing research team: Recruit, mentor, and guide a multidisciplinary team while ensuring scientific excellence, quality, and reproducibility.
Shape European clinical trial strategies in cellular and immuno-therapies: Actively contribute to and engage in study committees of European Clinical Trial Groups to advance the development, design, and clinical implementation of innovative cellular and immunotherapeutic approaches.
MD/PhD, MD or PhD in biomedical sciences, with demonstrated deep expertise in at least one area of cellular or immuno-therapy (e.g. cell engineering, immune modulation, or cancer vaccines), with a clear scientific profile and differentiation.
Postdoctoral research experience, with a proven track record in developing cell‑based therapies or leading immuno‑oncology research programs.
Strong understanding of preclinical models, regulatory frameworks, and requirements for early‑phase clinical translation of cell therapies.
Experience collaborating with clinical trial units and contributing to translational planning for first‑in‑human or Phase I studies.
Demonstrated ability to secure competitive external funding and lead an independent, internationally visible research program.
Strong leadership and mentoring skills (incl. education and training), with experience managing multidisciplinary scientific teams.
Excellent collaboration skills at the interface of research, clinical development, and GMP manufacturing.
Strong publication record in relevant cellular therapy, immuno-therapy or immune-engineering fields.
Fluency in English; international research experience is an advantage.
Our offer
Internal funding & strong institutional commitment: Competitive core budget and comprehensive start-up resources including dedicated laboratory space, access to core equipment, and support in building and scaling your independent research team.
Access to cutting‑edge research infrastructure: State‑of‑the‑art technology platforms in genomics, imaging, proteomics, high‑throughput screening, and advanced in‑vivo models.
Embedded collaborative ecosystem: Close interaction with clinicians at the St. Anna Children's Hospital, precision oncology initiatives, and interdisciplinary research groups within a highly translational environment.
Professional grant support: Institutional assistance with proposal development and grant management.
Attractive employment conditions, culture & location: Flexible working arrangements, tailored onboarding support for international researchers, and a diverse, mission‑driven culture committed to scientific excellence and improving outcomes for children with cancer, based in Vienna, offering outstanding quality of life and a strong biomedical ecosystem.
Compensation: The minimum annual gross salary for this position is € 78.000.- (all in), with the possibility of higher compensation depending on qualifications and experience.
Contract terms: The appointment will be made commensurate with seniority and experience. For Starting Principal Investigators, an initial 5‑year appointment with the possibility of a further 4‑year extension following a positive evaluation is foreseen, supporting the establishment of an independent research program. For Senior Principal Investigators, the position may be offered on a rolling tenure basis, with regular evaluations every 5 years, reflecting the institute's long‑term strategic commitment to research leadership.
Your application
We are looking forward to your application! The application deadline ends on 23.08.2026.
Please submit the following documents:
In case of questions please contact us at faculty-recruiting@ccri.at.
Your recruiting process
Our recruitment process is designed to ensure a fair, transparent, and rigorous evaluation. It includes the following steps:
Where cutting‑edge science meets real clinical decisions, precision oncology makes the difference!
Precision oncology has the power to redefine how children with cancer are diagnosed and treated and at St. Anna Children's Cancer Research Institute (St. Anna CCRI), we are taking this promise to the next level.
To strategically expand our institutional precision medicine program, we are seeking an outstanding Head of Precision Oncology to shape and lead a flagship initiative at the interface of research, molecular diagnostics, and clinical care. In this role, you will play a pivotal part in translating cutting‑edge molecular insights into individualized treatment strategies for pediatric cancer patients. This position is open to candidates at different career stages.
Establish and lead the institutional precision oncology program: Strategically develop and oversee molecular profiling, functional drug sensitivity testing, and multi‑omics integration in close clinical partnership with the St. Anna Children's Hospital.
Build and operate advanced laboratory and analytical infrastructures: Design and manage state‑of‑the‑art platforms ensuring high quality standards, efficiency, and scalability.
Translate multi‑omics data into clinical decision‑making: Integrate genomic and functional data to enable personalized treatment strategies for pediatric cancer patients.
Drive innovation and technology development: Implement next‑generation sequencing, data analytics, and functional precision medicine approaches.
Strengthen translational and clinical trial interfaces: Collaborate closely with the St. Anna CCRI Clinical Trials Unit, the clinical diagnostics laboratory Labdia (St. Anna CCRI subsidiary), and oncology teams (i.e., national and international PIs at the St. Anna Children's Hospital) to support biomarker-driven studies, patient selection, and early-phase translation.
Leadership, visibility & sustainability: Build and lead a high‑performing multidisciplinary team, represent the precision oncology program in national and international networks, and secure competitive funding to ensure long‑term sustainability.
PhD or MD/PhD in biomedical sciences, with deep expertise in molecular oncology, genomics, functional drug profiling, or computational precision medicine.
Several years of experience in leading translational precision medicine programs or multi-omics pipelines.
Strong technical understanding of sequencing technologies (e.g. WGS, WES, RNA‑seq, long‑read sequencing) and liquid biopsy assays.
Familiarity with diagnostic workflows, molecular tumor boards, and clinical trial data structures.
Demonstrated success in securing competitive third‑party funding and leading independent research programs.
Strong leadership and mentoring skills (incl. education and training), with experience building and managing interdisciplinary teams.
Excellent collaboration skills at the interface of research, clinical oncology, and diagnostic laboratories.
Strong publication record and visibility in the field of precision oncology.
Excellent English skills for scientific, clinical, and operational communication; German is an advantage.
Our offer
Strong institutional commitment & sustainable funding: Long‑term strategic investment and stable internal funding to establish and expand precision oncology as a core institutional program, complemented by active support in acquiring third‑party funding.
Embedded translational ecosystem: Close integration with clinical care at St. Anna Children's Hospital, precision medicine initiatives, the clinical diagnostics laboratory Labdia (St. Anna CCRI subsidiary), St. Anna CCRI Clinical Trials Unit, and advanced multi‑omics and bioinformatics platforms.
Excellent infrastructure & start‑up resources: Access to state‑of‑the‑art laboratory space, technology platforms (genomics, proteomics, imaging, drug screening), and support in building and scaling a high‑performing team.
Professional institutional support: Well‑established support structures for quality management, IT, grant management and other internal support functions.
Attractive employment conditions & location: Competitive remuneration, flexible working arrangements, tailored onboarding support for international candidates, and a mission‑driven, collaborative environment based in Vienna, offering outstanding quality of life and a strong biomedical ecosystem.
Compensation: The minimum annual gross salary for this position is € 73.000.- (all in), with the possibility of higher compensation depending on qualifications and experience.
Contract terms: The initial appointment is for 2 years. Subject to a positive evaluation, a rolling tenure with regular evaluations is foreseen, reflecting the institute's long‑term strategic commitment to this role.
Your application
We are looking forward to your application! The application deadline ends on 16.08.2026.
Please submit the following documents:
In case of questions please contact us at faculty-recruiting@ccri.at.
Your recruiting process
Our recruitment process is designed to ensure a fair, transparent, and rigorous evaluation. It includes the following steps:
Lead the next chapter of an established biobank shaping the future of pediatric cancer research!
At the St. Anna Children's Cancer Research Institute (St. Anna CCRI), science and clinical care are inseparably linked by a shared mission: improving the lives of children with cancer. This open role builds on an existing, actively used biobank infrastructure, embedded in routine diagnostics and numerous ongoing clinical trials.
We are now seeking an exceptional Head of Biobank to strategically modernize, consolidate, and further integrate this long‑standing biobank into a state‑of‑the‑art, certified infrastructure, including a sustainable digital database linked to clinical, diagnostic, and research data. This position is open to candidates at different career stages.
This is a rare opportunity to lead a state-of-the-art biobank that directly fuels precision oncology, cutting edge multi-omics research, and clinical innovation, turning high quality biospecimens into tangible breakthroughs for patients.
Lead and further develop a certified biobank: Consolidate and modernize a long‑standing biospecimen collection, covering collection, processing, storage, and governance, and integrate it into a modern, database‑driven infrastructure linked to clinical, diagnostic, and research data.
Strategic development & quality excellence: Define the biobank's long‑term strategy, infrastructure, and workflows, ensuring compliance with regulatory, ethical, biosafety, and ISO quality standards.
Clinical trial‑embedded biobanking: Oversee biospecimen acquisition, processing, and storage within numerous ongoing national and international clinical trials, respecting study‑specific regulatory requirements, material types, and defined time points.
Robust governance & lifecycle management: Ensure full sample lifecycle governance, including consent, traceability, documentation, data integrity, and transparent access processes for researchers.
Digital & infrastructural innovation: Lead the integration of existing biobank collections into a modern database environment, including metadata harmonization, linkage to clinical, diagnostic, and research data, and implementation of query interfaces for internal and external scientific users.
Institutional & translational collaboration: Act as a central interface to the clinical diagnostics laboratory Labdia (St. Anna CCRI subsidiary), Precision Oncology, the St. Anna CCRI Clinical Trials Unit, pathology partners, and research groups to support translational research pipelines.
Leadership, visibility & sustainability: Build and lead a high‑performing team, represent the biobank in national and international networks, and secure funding to ensure long‑term sustainability.
Our offer
Strong institutional commitment & sustainable funding: Long‑term investment and stable internal funding to establish and operate a certified, state‑of‑the‑art biobank as a core institutional infrastructure, complemented by support for third‑party funding acquisition.
Embedded translational ecosystem: Close integration with clinical care, precision oncology, diagnostics, clinical trials, and advanced multi‑omics and digital pathology platforms.
Professional institutional support: Well‑established support structures for quality management, IT, grant management and other internal support functions.
Attractive employment conditions: Competitive remuneration, flexible working arrangements, and tailored onboarding support for international candidates.
Mission‑driven culture & location: A collaborative, purpose‑driven institute dedicated to improving outcomes for children with cancer, based in Vienna, offering excellent quality of life and a strong biomedical ecosystem.
Compensation: The minimum annual gross salary for this position is € 73.000.- (all in), with the possibility of higher compensation depending on qualifications and experience.
Contract terms: The initial appointment is for 2 years. Subject to a positive evaluation, a rolling tenure with regular evaluations is foreseen, reflecting the institute's long‑term strategic commitment to this role.
Who we are
One of Europe's leading institutions in the field of pediatric oncology, St. Anna Children's Cancer Research Institute (St. Anna CCRI) investigates the biological foundations of cancer in children and adolescents. For almost 40 years, our multidisciplinary teams have been committed to developing innovative diagnostic approaches and personalized treatments aimed at further improving young patients' chances of cure. In close collaboration with the St. Anna Children's Hospital and both national and international partners, we combine scientific excellence with clinical relevance. We stand for responsible research, transparency, and sustainable knowledge building. As an employer, we offer a state-of-the-art research environment, opportunities for professional development, as well as a workplace culture that embraces diversity and appreciation. Work where it really matters and contribute to science that makes a difference.
St. Anna CCRI is an equal opportunity employer. We value diversity and are committed to providing a work environment of mutual respect to everyone without regard to race, colour, religion, national origin, age, gender identity or expression, disability, or any other characteristic protected by applicable laws, regulations and ordinances.
Find more information here: https://ccri.at/.
Your application
We are looking forward to your application! Applications will be reviewed on a rolling basis until the position is filled.
Please submit the following documents:
In case of questions please contact us at faculty-recruiting@ccri.at.
Your recruiting process
Our recruitment process is designed to ensure a fair, transparent, and rigorous evaluation. It includes the following steps:
